Every compound, honestly graded

Melanocortin-receptor agonist approved for hypoactive sexual desire disorder in premenopausal women.

Also known as Bremelanotide, Vyleesi

Copper-binding tripeptide used topically for skin remodelling.

Also known as Copper peptide, Glycyl-L-histidyl-L-lysine copper

Synthetic pentadecapeptide from a gastric protein, studied preclinically for tissue repair.

Also known as Body Protection Compound 157, PL 14736, Pentadecapeptide BPC 157

Synthetic fragment related to thymosin beta-4, studied preclinically for tissue repair.

Also known as Thymosin Beta-4 fragment, TB4 fragment

Synthetic tetrapeptide studied in Russian gerontology literature for telomerase activity.

Also known as Epithalon, Epithalamin, AEDG

Tripeptide C-terminal fragment of alpha-MSH studied for anti-inflammatory effects.

Also known as Lysine-Proline-Valine, alpha-MSH 11-13

Mitochondrial-derived peptide studied in metabolic regulation and exercise physiology.

Also known as MOTSc, Mitochondrial ORF of the 12S rRNA type-c

Synthetic ACTH fragment analogue used in Russia for cognitive and neurological indications.

Also known as ACTH(4-7)PGP, Met-Glu-His-Phe-Pro-Gly-Pro

Nonapeptide first isolated from rabbit cerebral venous blood, studied for sleep.

Also known as Delta Sleep-Inducing Peptide, Emideltide

Approved nonapeptide hormone; compounded intranasal forms are used off-label.

Also known as Pitocin

Synthetic GHRH analogue, with and without drug-affinity complex.

Also known as Modified GRF(1-29), CJC-1295 DAC

Selective ghrelin-receptor agonist and growth-hormone secretagogue.

Also known as NNC 26-0161

Thymic peptide used outside the US as an immune modulator in hepatitis and sepsis.

Also known as Thymalfasin, Zadaxin, Ta1

Growth-hormone fragment studied for lipolysis; failed its obesity endpoint in human trials.

Also known as hGH fragment 176-191

Growth-hormone-releasing peptide and ghrelin-receptor agonist.

Also known as Pralmorelin

Growth-hormone-releasing peptide with marked appetite stimulation.

Also known as Growth Hormone Releasing Peptide-6

Modified insulin-like growth factor 1 analogue sold as a research reagent.

Also known as Long R3 IGF-1

Unapproved melanocortin agonist sold online for tanning; associated with safety reports.

Also known as MT-2, MT-II

Synthetic tuftsin analogue used in Russia for anxiety.

Also known as TP-7, Tuftsin analogue

Mitochondria-targeting tetrapeptide investigated in mitochondrial myopathy.

Also known as Elamipretide, Bendavia, MTP-131

Actin-sequestering peptide studied in wound healing and cardiac repair.

Also known as Tβ4, TB4

Erythropoietin-derived peptide studied in small-fibre neuropathy.

Also known as Cibinetide

Porcine brain-derived peptide preparation used outside the US in stroke and dementia.

Angiotensin IV analogue studied preclinically as an HGF/c-Met potentiator.

Also known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide

Synthetic hexapeptide growth-hormone secretagogue.

Also known as Examorelin

Mitochondrial-derived peptide studied in cytoprotection and ageing.

Also known as HN, MDP

Tight-junction regulator peptide investigated in coeliac disease.

Also known as AT-1001, INN-202

Human cathelicidin antimicrobial peptide studied in innate immunity.

Also known as Cathelicidin LL-37

Peptide studied preclinically for neurogenesis.

Also known as Cerebrolysin-derived peptide

Dual GIP/GLP-1 receptor agonist approved for type 2 diabetes and obesity.

Also known as Mounjaro, Zepbound

Investigational triple GIP/GLP-1/glucagon receptor agonist; not approved and not compoundable.

Also known as LY3437943

Daily GLP-1 receptor agonist approved for diabetes and weight management.

Also known as Saxenda, Victoza

Weekly GLP-1 receptor agonist approved for type 2 diabetes.

Also known as Trulicity

First-in-class GLP-1 receptor agonist derived from exendin-4.

Also known as Byetta, Bydureon

Investigational long-acting amylin analogue studied with semaglutide.

Also known as AM833

Investigational GLP-1/glucagon receptor agonist.

Also known as LY3305677, IBI362

Investigational dual glucagon/GLP-1 receptor agonist.

Also known as BI 456906

Primary human oestrogen, approved in oral, transdermal and vaginal forms.

Also known as 17β-estradiol, Estrace

Approved progestogen used in menopausal hormone therapy.

Also known as Micronised progesterone, Prometrium

Schedule III androgen approved for male hypogonadism.

Also known as Testosterone cypionate, Testosterone enanthate

Adrenal precursor steroid, sold as a supplement and as an approved vaginal insert.

Also known as Dehydroepiandrosterone, Prasterone

Approved gonadotropin used in fertility and hypogonadism protocols.

Also known as Human chorionic gonadotropin, Pregnyl

Opioid antagonist approved at 50 mg, compounded at 1–5 mg for off-label immune indications.

Also known as LDN, low dose naltrexone

First-line biguanide for type 2 diabetes, studied in the TAME geroscience trial.

Also known as Glucophage

mTOR inhibitor approved as an immunosuppressant, studied off-label in geroscience.

Also known as Sirolimus, Rapamune

Aromatase inhibitor approved in breast cancer, used off-label in hormone protocols.

Also known as Arimidex

Approved for methaemoglobinaemia; studied at low dose in mitochondrial and cognitive research.

Also known as Methylthioninium chloride, Provayblue

Selective oestrogen-receptor modulator studied for secondary hypogonadism; not FDA-approved.

Also known as Enclomiphene citrate

Orally active non-peptide ghrelin-receptor agonist; investigational, not approved.

Also known as Ibutamoren, Ibutamoren mesylate

Gut-microbial ellagitannin metabolite studied for mitophagy and muscle endurance.

Also known as Mitopure

Semi-synthetic polysaccharide approved for interstitial cystitis.

Also known as Elmiron

Polyamine studied as an autophagy inducer in ageing research.

Essential redox cofactor central to mitochondrial metabolism and sirtuin signalling.

Also known as Nicotinamide adenine dinucleotide, NAD

Endogenous tripeptide antioxidant used in compounded injectable and inhaled forms.

Also known as GSH, L-glutathione

NAD+ precursor; FDA has excluded it from the dietary-supplement definition.

Also known as Nicotinamide mononucleotide

NAD+ precursor marketed as a dietary ingredient with human pharmacokinetic data.

Also known as NR, Niagen